We provide targeted intelligence and research support across the questions that shape clinical development, competitive positioning, regulatory strategy, market access and commercial execution.
Understand competitor pipelines, clinical development, launch preparation, strategic moves and likely responses.
Targeted interviews with HCPs, KOLs, payers and industry experts built around explicit KIQs.
Track trial progress, evidence interpretation, readout expectations and clinical differentiation.
Assess positioning, messaging, launch readiness, customer perceptions, access and competitive response.
Follow filing strategy, milestones, approval expectations, label evolution and market sequencing.
Turn major congresses and data events into targeted follow-up research and decision-relevant synthesis.
Maintain focused tracking across competitor, pipeline, clinical, regulatory, congress and company developments.
A tightly scoped engagement for a defined question, moving quickly from KIQ definition to research and synthesis.
A broader research program around a strategic question, competitive event, asset or market development.
A recurring intelligence relationship for monitoring, selected primary research and rapid response.
Assignments can focus on a single asset, a defined competitor set, a market or a specific event. The research plan is sized to the decision, timing and evidence gap.
Trial progress, clinical positioning, endpoints, development plans, readout expectations, regulatory milestones and potential differentiation.
Typical output: asset profiles, milestone trackers, competitor comparisons and source-backed assessments.Target customer priorities, treatment pathways, access considerations, field activity, messaging themes, adoption barriers and launch sequencing.
Typical output: market maps, stakeholder perspectives, launch-readiness views and strategic implications.Interview design, respondent mapping, discussion guides, expert conversations, transcript development and KIQ-led synthesis.
Typical output: interview transcripts, quote banks, source-level findings and cross-source analysis.Focused monitoring around congresses, clinical readouts, regulatory decisions, competitor announcements and portfolio developments.
Typical output: rapid readouts, event trackers, implications briefs and follow-up research priorities.Grapon can support a defined workstream from research design through final synthesis, or provide focused capacity for a specific stage such as expert identification, primary interviews, transcript development, secondary research or evidence triangulation. Scope, source requirements and output format are agreed at the start of each engagement.
We can combine multiple capabilities around the decision you need to support.
